Comparison of the tolerability of terbium-161 and lutetium-177 in combination with somatostatin analogues in the preclinical setting
Preprint in bioRxiv (March 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Opportunities and potential challenges of using terbium-161 for targeted radionuclide therapy in clinics
Article in European Journal of Nuclear Medicine and Molecular Imaging (July 2023)
Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [177Lu]Lu-DOTATATE Treatment
Article in Journal of Nuclear Medicine (June 2023)